PharmaShots | Incisive News in 3 Shots

Subscribe Now

one prior therapy

BeiGene's Brukinsa (zanubrutinib) Receives the US FDA's Accelerated Approval for Patients with Mantle Cell Lymphoma Who Received At least One Prior Therapy

BeiGene's Brukinsa (zanubrutinib) Receives the US FDA's Accelerated Approval for Patients with Mantle Cell Lymphoma Who Received A...

November 15, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us